BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27892633)

  • 1. Dihydroavenanthramide D inhibits mast cell degranulation and exhibits anti-inflammatory effects through the activation of neurokinin-1 receptor.
    Lotts T; Agelopoulos K; Phan NQ; Loser K; Schmaus G; Luger TA; Ständer S
    Exp Dermatol; 2017 Aug; 26(8):739-742. PubMed ID: 27892633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 1 Receptor Antagonists for Pruritus.
    Alam M; Buddenkotte J; Ahmad F; Steinhoff M
    Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity.
    Sur R; Nigam A; Grote D; Liebel F; Southall MD
    Arch Dermatol Res; 2008 Nov; 300(10):569-74. PubMed ID: 18461339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and streptozotocin toxicity.
    Lv N; Song MY; Lee YR; Choi HN; Kwon KB; Park JW; Park BH
    Biochem Biophys Res Commun; 2009 Sep; 387(1):97-102. PubMed ID: 19576175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression.
    Lee YR; Noh EM; Oh HJ; Hur H; Kim JM; Han JH; Hwang JK; Park BH; Park JW; Youn HJ; Jung SH; Kim BS; Jung JY; Lee SH; Park CS; Kim JS
    Biochem Biophys Res Commun; 2011 Feb; 405(4):552-7. PubMed ID: 21262201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats.
    Erin N; Ersoy Y; Ercan F; Akici A; Oktay S
    Clin Exp Dermatol; 2004 Nov; 29(6):644-8. PubMed ID: 15550145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
    Ohanyan T; Schoepke N; Eirefelt S; Hoey G; Koopmann W; Hawro T; Maurer M; Metz M
    Acta Derm Venereol; 2018 Jan; 98(1):26-31. PubMed ID: 28853492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
    Remröd C; Lonne-Rahm S; Nordlind K
    Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.
    Zhan M; Zheng W; Jiang Q; Zhao Z; Wang Z; Wang J; Zhang H; He S
    Cell Biol Toxicol; 2017 Aug; 33(4):389-405. PubMed ID: 28154998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of itch and new treatments.
    Raap U; Ständer S; Metz M
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):420-7. PubMed ID: 21772138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of substance P in stress-derived degranulation of dermal mast cells in mice.
    Kawana S; Liang Z; Nagano M; Suzuki H
    J Dermatol Sci; 2006 Apr; 42(1):47-54. PubMed ID: 16412613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK-1 Antagonists and Itch.
    Ständer S; Luger TA
    Handb Exp Pharmacol; 2015; 226():237-55. PubMed ID: 25861784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of substance P activity prevents stress-induced bladder damage.
    Ercan F; Akici A; Ersoy Y; Hürdag C; Erin N
    Regul Pept; 2006 Jan; 133(1-3):82-9. PubMed ID: 16239038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
    Ständer S; Spellman MC; Kwon P; Yosipovitch G
    Expert Opin Investig Drugs; 2019 Aug; 28(8):659-666. PubMed ID: 31272246
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of prostaglandin D2 through the p38 MAPK pathway is responsible for the antipruritic activity of sertaconazole nitrate.
    Kaur S; Sur R; Liebel FT; Southall MD
    J Invest Dermatol; 2010 Oct; 130(10):2448-56. PubMed ID: 20505747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research in practice: substance P antagonism in chronic pruritus.
    Lotts T; Ständer S
    J Dtsch Dermatol Ges; 2014 Jul; 12(7):557-9. PubMed ID: 24862239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin inhibits IL-31 production in stimulated human mast cells: Possibilities of fisetin being exploited to treat histamine-independent pruritus.
    Che DN; Cho BO; Shin JY; Kang HJ; Kim YS; Jang SI
    Life Sci; 2018 May; 201():121-129. PubMed ID: 29604269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
    Wang LL; Han Y; Guo Z; Han SQ; Liu T
    Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on substance P in the regulation of degranulation of cultured murine mast cells].
    Cheng FL; Li QT; Zhao CQ; An YF; Qi XP
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Sep; 51(9):675-680. PubMed ID: 27666706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.